Feedback / Questions
GYA01 - Gyala Therap
https://www.prnewswire.com/news-releases/gyala-therapeutics-unveils-first-in-class-car-t-therapy-targeting-cd84-showing-strong-preclinical-efficacy-in-hard-to-treat-leukemias-302554162.html
Sep 15, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next